Funding · Company
Outpace Bio, Inc.
Seattle, WABiotech & Pharma
Outpace Bio, Inc. of Seattle, WA has disclosed $56M across 1 Form D offering filed with the SEC on Aug 1, 2024.
$56M
Total disclosed
1
Form D offering
2020
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$56M
Form D · Aug 1, 2024 ↗
Q3 2024
· target $144M
Filing details
HeadquartersSeattle, WAIndustryBiotech & Pharma (Biotechnology)Incorporated2020SEC CIK0002031531Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →